275 related articles for article (PubMed ID: 1641114)
1. Cerebrovascular effects and tumor kinetics after a single intratumoral injection of human recombinant interleukin-2 alone or in combination with intravenous chemotherapy in a rat model of glioma.
Watts RG; Merchant RE
Neurosurgery; 1992 Jul; 31(1):89-98; discussion 98-9. PubMed ID: 1641114
[TBL] [Abstract][Full Text] [Related]
2. Acute effects of human recombinant tumor necrosis factor-alpha on the cerebral vasculature of the rat in both normal brain and in an experimental glioma model.
Kido G; Wright JL; Merchant RE
J Neurooncol; 1991 Apr; 10(2):95-109. PubMed ID: 1716671
[TBL] [Abstract][Full Text] [Related]
3. Histopathological and blood-brain barrier changes in rats induced by an intracerebral injection of human recombinant interleukin 2.
Watts RG; Wright JL; Atkinson LL; Merchant RE
Neurosurgery; 1989 Aug; 25(2):202-8. PubMed ID: 2788827
[TBL] [Abstract][Full Text] [Related]
4. Effects of an intratumoral injection of human recombinant tumor necrosis factor-alpha on cerebrovascular permeability and leukocytic infiltration in a rat glioma model.
Wright JL; Merchant RE
Acta Neuropathol; 1997 Jan; 93(1):78-86. PubMed ID: 9006660
[TBL] [Abstract][Full Text] [Related]
5. Systemic treatment with murine recombinant interleukin-1 beta inhibits the growth and progression of malignant glioma in the rat.
Rice CD; Merchant RE
J Neurooncol; 1992 May; 13(1):43-55. PubMed ID: 1613537
[TBL] [Abstract][Full Text] [Related]
6. Anti-tumor activity of interleukin-2-producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system.
Kikuchi T; Joki T; Saitoh S; Hata Y; Abe T; Kato N; Kobayashi A; Miyazaki T; Ohno T
Int J Cancer; 1999 Jan; 80(3):425-30. PubMed ID: 9935185
[TBL] [Abstract][Full Text] [Related]
7. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.
Merchant RE; McVicar DW; Merchant LH; Young HF
J Neurooncol; 1992 Jan; 12(1):75-83. PubMed ID: 1541981
[TBL] [Abstract][Full Text] [Related]
8. Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.
Kruse CA; Lillehei KO; Mitchell DH; Kleinschmidt-DeMasters B; Bellgrau D
Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9577-81. PubMed ID: 2263613
[TBL] [Abstract][Full Text] [Related]
9. Rat mitogen-stimulated lymphokine-activated T killer cells: production and effects on C6 glioma cells in vitro and in vivo in the brain of Wistar rats.
Carson WE; Jakowatz JG; Yamamoto R; Fitzgerald T; Gupta S; Vayuvegula B; Lucci JA; Beckman MT; Dulkanchainun S; Granger GA
J Immunother (1991); 1991 Apr; 10(2):131-40. PubMed ID: 2043593
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effect between intraneoplastic methotrexate and radiation on experimental intracerebral rat gliosarcoma.
Wilkinson HA; Fujiwara T; Rosenfeld S
Neurosurgery; 1994 Apr; 34(4):665-8; discussion 668. PubMed ID: 8008164
[TBL] [Abstract][Full Text] [Related]
11. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
12. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
13. Systemic chemotherapy combined with local adoptive immunotherapy cures rats bearing 9L gliosarcoma.
Kruse CA; Mitchell DH; Kleinschmidt-DeMasters BK; Bellgrau D; Eule JM; Parra JR; Kong Q; Lillehei KO
J Neurooncol; 1993 Feb; 15(2):97-112. PubMed ID: 8509824
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of local immunochemotherapy of head and neck cancer].
Saito T
Nihon Jibiinkoka Gakkai Kaiho; 1991 Dec; 94(12):1898-912. PubMed ID: 1779275
[TBL] [Abstract][Full Text] [Related]
15. Local immunotherapy with interleukin-2 delivered from biodegradable polymer microspheres combined with interstitial chemotherapy: a novel treatment for experimental malignant glioma.
Rhines LD; Sampath P; DiMeco F; Lawson HC; Tyler BM; Hanes J; Olivi A; Brem H
Neurosurgery; 2003 Apr; 52(4):872-9; discussion 879-80. PubMed ID: 12657184
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model.
Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB
Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246
[TBL] [Abstract][Full Text] [Related]
17. Brain tumor-targeted delivery and therapy by focused ultrasound introduced doxorubicin-loaded cationic liposomes.
Lin Q; Mao KL; Tian FR; Yang JJ; Chen PP; Xu J; Fan ZL; Zhao YP; Li WF; Zheng L; Zhao YZ; Lu CT
Cancer Chemother Pharmacol; 2016 Feb; 77(2):269-80. PubMed ID: 26666650
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor effect of intra-arterial tumor necrosis factor-alpha in rats with transplanted intracerebral glioma and its evaluation by MRI].
Harada K; Yoshida J; Wakabayashi T; Sugita K; Kurisu K; Uozumi T; Zieroth BF; Takahashi M; Yamanaka T
No Shinkei Geka; 1995 Dec; 23(12):1069-74. PubMed ID: 8927213
[TBL] [Abstract][Full Text] [Related]
19. A model for evaluating therapeutic response of combined cancer treatment modalities: applied to treatment of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and 60Co-gamma radiation (RT).
Persson BR; Bauréus Koch C; Grafstrom G; Engstrom PE; Salford LG
Technol Cancer Res Treat; 2003 Oct; 2(5):459-70. PubMed ID: 14529312
[TBL] [Abstract][Full Text] [Related]
20. Pulsed high-intensity focused ultrasound enhances the relative permeability of the blood-tumor barrier in a glioma-bearing rat model.
Yang FY; Lin GL; Horng SC; Chang TK; Wu SY; Wong TT; Wang HE
IEEE Trans Ultrason Ferroelectr Freq Control; 2011 May; 58(5):964-70. PubMed ID: 21622052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
